CAENORHABDITIS-ELEGANS GENE CED-9 PROTECTS CELLS FROM PROGRAMMED CELL-DEATH

被引:709
作者
HENGARTNER, MO
ELLIS, RE
HORVITZ, HR
机构
[1] Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
[2] Laboratory of Molecular Biology, University of Wisconsin at Madison, Madison, WI 53706
关键词
D O I
10.1038/356494a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The gene ced-9 of the nematode Caenorhabditis elegans acts to protect cells from programmed cell death. A mutation that abnormally activates ced-9 prevents the cell deaths that occur during normal C. elegans development. Conversely, mutations that inactivate ced-9 cause cells that normally live to undergo programmed cell death; these mutations result in embryonic lethality, indicating that ced-9 function is essential for development. The ced-9 gene functions by negatively regulating the activities of other genes that are required for the process of programmed cell death.
引用
收藏
页码:494 / 499
页数:6
相关论文
共 40 条
[1]   PHARYNX OF CAENORHABDITIS ELEGANS [J].
ALBERTSON, DG ;
THOMSON, JN .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1976, 275 (938) :299-&
[2]   A CELL THAT DIES DURING WILD-TYPE C-ELEGANS DEVELOPMENT CAN FUNCTION AS A NEURON IN A CED-3 MUTANT [J].
AVERY, L ;
HORVITZ, HR .
CELL, 1987, 51 (06) :1071-1078
[3]   TROPHIC FACTORS AND NEURONAL SURVIVAL [J].
BARDE, YA .
NEURON, 1989, 2 (06) :1525-1534
[4]  
BRENNER S, 1974, GENETICS, V77, P71
[5]   GENETIC-ANALYSIS OF TEMPERATURE-SENSITIVE EMBRYOGENESIS MUTANTS IN CAENORHABDITIS-ELEGANS [J].
CASSADA, R ;
ISNENGHI, E ;
CULOTTI, M ;
VONEHRENSTEIN, G .
DEVELOPMENTAL BIOLOGY, 1981, 84 (01) :193-205
[6]  
CHALFIE M, 1988, NEMATODE CAENORHABDI, P337
[7]   GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634
[8]   PREVENTION OF APOPTOSIS BY A BACULOVIRUS GENE DURING INFECTION OF INSECT CELLS [J].
CLEM, RJ ;
FECHHEIMER, M ;
MILLER, LK .
SCIENCE, 1991, 254 (5036) :1388-1390
[9]  
COHEN JJ, 1984, J IMMUNOL, V132, P38
[10]  
DESAI C, 1989, GENETICS, V121, P703